Blue Cross and Blue Shield of Texas announced it has made the decision to remove MD Anderson Cancer Center in Houston from ...

Blue Cross and Blue Shield of Texas said MDA will no longer be in its Medicare Advantage (PPO)SM or Blue Cross Medicare Advantage (HMO)SM as of Nov. 1, 2024.

Clinical trials of single-agent targeted drugs have shown limited efficacy. In the only trial of single-agent immunotherapy ...

Just two of the state’s most populous counties — Denton and Fort Bend — have broken their turnout records during the first ...

By Nov. 1, MD Anderson's agreement with Blue Cross Blue Shield Medicare Advantage will expire, leaving patients on that plan ...

A recent study delves into the subtle ways that tobacco and smoking use is being promoted on streaming platforms.

MD Anderson Cancer Center is bringing a new diagnostic imaging clinic to the northwest Houston area, according to a project ...

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination ...

Discover the latest developments in cancer research as the University of Texas MD Anderson Cancer Center begins construction on a state-of-the-art biosciences ...

Researchers conducted a subgroup analysis of POSEIDON trial data, then characterized underlying biologic mechanisms using mouse models.

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.